Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of migraine (with or without aura) or cluster headache according to the International Classification of Headache Disorders, Version 2 (ICHD-II)
History of migraine or cluster headache persisting for at least 6 months
Migraine: One to 6 attacks of moderate or severer headaches per month during the 2 months prior to enrollment
Cluster Headache: Each attack persisting for at least 45 minutes
Written informed consent obtained from the patient. When a patient is a minor, written informed consent from his/her proxy consenter (e.g., person with parental authority) will also be required.
You may not be if
History of hypersensitivity to any of the ingredients of 5-HT1B/1D receptor antagonists (e.g., triptans) or serious AE due to treatment with these drugs
History of serious adverse event attributable to treatment with Imigran® Injection 3
History of myocardial infarction, current or previous history of ischemic heart disease or its symptoms/signs, or current history of atypical variant angina (coronary arteriospasm)
Previous history of cerebrovascular disorder or transient cerebral ischemic attack
Current or previous history of peripheral angiopathy (including Raynaud's syndrome)
Systolic blood pressure (SBP) \>160 mmHg or diastolic blood pressure (DBP) \>95 mmHg at the start of treatment period
Current familial hemiplegic migraine, basilar migraine, or sporadic hemiplegic migraine
Current abuse of ergotamine- or dihydroergotamine-containing preparations or triptans
Pregnant women, lactating mothers, women who may be pregnant, or women of childbearing potential using no appropriate contraceptive measures.
Epilepsy or organic cerebral disorder which may lead to convulsion
Previous history of hypersensitivity to sulfonamides
Known drug allergy or idiosyncrasies
Known drug dependency or alcoholism
Clareo Health | Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
